• Keros Therapeutics (NASDAQ:KROS) Receives Buy Rating from HC Wainwright

    Source: Buzz FX / 07 Nov 2024 08:26:16   America/Chicago


    Keros Therapeutics (NASDAQ:KROS) Receives Buy Rating from HC Wainwright Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Keros Therapeutics ( NASDAQ:KROS - Get Free Report ) 's stock had its "buy" rating reissued by eq
    Read more...
Share on,